# Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia

> **NCT04291469** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 200 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Probiotics（Live combined bifidobacteria, lactobacillus and maltodextrin tables)
- **DIETARY_SUPPLEMENT:** Prebiotics (Combined inulin and maltodextrin tables)
- **DIETARY_SUPPLEMENT:** maltodextrin

## Key facts

- **NCT ID:** NCT04291469
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-03
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04291469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04291469, "Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04291469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*